Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

Clinical trial NCT07613099 · RECRUITING

Trial details

NCT number: NCT07613099
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Allogeneic Stem Cell Transplantation Lung Allograft Transplantation Interstitial Lung Disease Acute Lung Injury Pulmonary Arterial Hypertension Cardiovascular Diseases

Start date: 2026-08-26
Primary completion: 2031-05-26
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.